Clinical trial · Observational
Finding Predictors of Side Effects to Chemoradiation Treatment in Elderly Patients With Head and Neck Cancer
Identification of Predictors of Tolerance to Chemoradiotherapy in Elderly Patients With Head and Neck Cancer
NCT01688323CI-TRIAL-00029501completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To look at what types of measures can be used to predict how an older person will tolerate chemoradiation treatment for head and neck cancer. This study uses surveys and a blood draw to look at the different measures.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Collect Blood and Survey Instruments | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Elderly Chemorads
- description
- Elderly patients with Head and Neck Cancer who are Undergoing Chemotherapy
- interventionNames
- Other: Collect Blood and Survey Instruments
Primary outcomes (1)
- measure
- Significant Change in Function from Baseline to Post-Treatment
- timeFrame
- 2 years
- description
- To determine if there is a significant change in the Instrumental Activities of Daily Living (IADL) subscore of the Geriatric Assessment (GA) from baseline to 90 days post-treatment.
Secondary outcomes (5)
- measure
- Explore Association between Baseline Measures and Decline in Living Status
- timeFrame
- 2 years
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria * Patients will be eligible for this protocol provided they have an appointment at the North Carolina Cancer Hospital (NCCH), have planned chemoradiotherapy for head and neck cancer (any histology) and consent to complete the Geriatric Assessment. No exclusions will be made based on gender, ethnicity, performance status or race. Patient must be able to read and speak English. * Signed, IRB approved written informed consent. * Age of at least 65 years. * Enrollment in other studies, both therapeutic and observational, will not result in exclusion. Exclusion Criteria * Inability to read and speak English. * Inability to comply with study for any other reason than language
References
Publications (0)
Data not yet available
No reference posted for this study.